Axen BRCA
Coming soon
Inherited (germline) testing of BRCA1 and BRCA2, the two genes most often examined for hereditary breast and ovarian cancer risk.
| Clinical purpose | Identifies inherited variants in BRCA1 and BRCA2. Results can inform personal and family risk and, in some cancers, treatment discussions with the oncologist. |
|---|---|
| Sample type | Confirmed when you enquire |
| Genes / regions covered | BRCA1, BRCA2 |
| Intended use | Germline testing, typically with genetic counselling. Not a tumour test. |
| Approximate turnaround | Confirmed when you enquire |
| Report type | NGS analysis report |
| Ordering requirements | Confirmed when you enquire |
| Price | Confirmed when you enquire |
Turnaround, price and sample requirements are confirmed when you enquire, so you never rely on an outdated figure. Whether this test is appropriate is a decision for the treating oncologist.